← Evidence map

ArticleFrontiers in cardiovascular medicine2022

Hemoclot Thrombin Inhibitor Assay and Expected Peak-Trough Levels of Dabigatran: A Multicenter Study.

Zhiyan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2022
this papercites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 35935625